(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Millennium Chelsea Harbour Hotel

May 10, 2017 9:00 AM - May 11, 2017 5:30 PM

Chelsea Harbour, London, SW10 0XG, United Kingdom

Pharmacovigilance Conference

Pharmacovigilance Update: Practical Approaches to Current Challenges - Interactive Session and Workshop Series

Back to Agenda

Session 6: Pharmacoepidemiological Studies for Pharmacovigilance Plan

Session Chair(s)

Katherine Donegan

Katherine Donegan

Head of Epidemiology

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Steve Hobbiger

Steve Hobbiger

Senior Vice President and QPPV, R&D

GlaxoSmithKline , United Kingdom

Studies proposed in a pharmacovigilance plan aim to characterise the main adverse drug reactions (ADRs) to be followed in the life cycle of medicinal products. With some examples, pros and cons of the methods to be used in pharmacovigilance plans will be presented.

Speaker(s)

Marianne Cunnington

Marianne Cunnington

GlaxoSmithKline, United Kingdom

Julia Stowe

Julia Stowe

Public Health England, United Kingdom

Researcher

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.